Sex differences in tolerability and response to immune checkpoint inhibitors in non-small cell lung cancer patients

被引：0
|
作者：
Duma, Narjust [1 ]
Azzouqa, Abdel-Ghani [1 ]
Yadav, Siddhartha [1 ]
Hoversten, Kahterine [1 ]
Reed, Clay [1 ]
Sitek, Andrea [1 ]
Enninga, Elizabeth [1 ]
Paludo, Jonas [1 ]
Kottschade, Lisa [1 ]
Mansfield, Aaron [1 ]
Manochakian, Rami [1 ]
Dronca, Roxana [1 ]
Adjei, Alex [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2020年 / 29卷 / 06期
关键词：
D O I：
10.1158/1538-7755.DISP18-A120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A120
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Jung, Chi Young
    Antonia, Scott J.
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2018, 81 (01) : 29 - 41
  • [22] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Lin, Gen
    Wang, Zhijie
    Chu, Qian
    Hu, Yi
    Huang, Dingzhi
    Wang, Jun
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Yutao, Liu
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    THORACIC CANCER, 2024, 15 (05) : 419 - 426
  • [23] Pneumonitis associated with immune checkpoint inhibitors among patients with non-small cell lung cancer
    Shannon, Vickie R.
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (04) : 326 - 340
  • [24] The role of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Pistamaltzian, Nikolaos F.
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) : 435 - 447
  • [25] Immune checkpoint inhibitors and driver oncogenes in non-small cell lung cancer
    Miura, Yosuke
    Kasahara, Norimitsu
    Sunaga, Noriaki
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S628 - S632
  • [26] Safety of current immune checkpoint inhibitors in non-small cell lung cancer
    Abdayem, Pamela
    Planchard, David
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 651 - 667
  • [27] Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
    Zhenbin Qiu
    Zihao Chen
    Chao Zhang
    Wenzhao Zhong
    Experimental Hematology & Oncology, 8
  • [28] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [29] Immune checkpoint inhibitors in therapy of non-small cell lung cancer (a review)
    Kolesnik, O. P.
    Mykhailychenko, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (03) : 418 - 425
  • [30] Incidence of Cardiotoxicity in Patients Treated for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Carpenter, I. N.
    Brice, K. B.
    Walker, D.
    Dumais, K.
    Alvarez, A. M.
    Cohen, N. S.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S629 - S629
12345